Inventor · disambiguated record
Jonas Bovijn
Also filed as: BOVIJN JONAS
2 granted patents·6 pending applications·0 citations·filing 2022–2025
31Inventor score
Files withREGENERON PHARMA8
Top patents by PatentIndex Score
8 records- 0177US12234460B2Methods of treating decreased bone mineral density with cluster of differentiation 109 (CD109) inhibitorsREGENERON PHARMA·Filed 2023·Granted Feb 25, 2025·0 cites·25 claims
- 0272US11891607B2Methods of treating decreased bone mineral density with cluster of differentiation 109 (CD109) inhibitorsREGENERON PHARMA·Filed 2022·Granted Feb 6, 2024·0 cites·18 claims
- 0363US2025092396A1Treatment Of Osteoarthritis With Cartilage Intermediate Layer Protein 2 (CILP2) InhibitorsREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 0462US2025236873A1Methods Of Treating Decreased Bone Mineral Density With Cluster Of Differentiation 109 (CD109) InhibitorsREGENERON PHARMA·Filed 2025·Application pending·0 cites
- 0561US2025129372A1Treatment Of Osteoarthritis With Procollagen Galactosyl Transferase 2 (COLGALT2) InhibitorsREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 0661US2024207204A1Treatment Of Type 2 Diabetes With Hepatocyte Nuclear Factor 4 Alpha (HNF4A) AgonistsREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 0759US2023021584A1Methods Of Treating Decreased Bone Mineral Density With Kringle Containing Transmembrane Protein 1 (KREMEN1) InhibitorsREGENERON PHARMA·Filed 2022·Application pending·0 cites
- 0857US2023083558A1Treatment of Decreased Bone Mineral Density With Wnt Family Member 5B (WNT5B) InhibitorsREGENERON PHARMA·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jonas Bovijn files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →